Calico Biosystems is a startup based in Switzerland.
Calico Biosystems is a company headquartered in Switzerland.
Calico Biosystems is a Lausanne-based company that provides a preclinical oncology drug development platform using New Approach Methodologies (NAM) to test drug efficacy directly on intact, cryopreserved patient tumors. Their proprietary stack combines global tumor sourcing, cryopreservation, and AI-driven efficacy scoring to deliver predictive efficacy data, indication prioritization, and experimental biomarkers for pharma and biotech clients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.